• Mayo Leads Global Study on Breast Drug Side Effect

    Updated: 2010-09-28 02:26:49
    Mayo Clinic researchers and their international colleagues have discovered genetic variants that lead to severe arthritis for a subset of women when taking aromatase inhibitors to treat their breast cancer. This serious side effect is so painful that many women halt their lifesaving medication. The findings appear today in the online issue of the Journal of [...]

  • Mind Training Helps MS Patients Cope With Disease

    Updated: 2010-09-27 21:00:00
    Multiple sclerosis patients can learn to cope better with the fatigue, depression, and anxiety that often accompany the disease, researchers said.

  • Hand Transplant Program Initiated at Mayo Clinic

    Updated: 2010-09-23 16:12:34
    Journalists:  For links to web-video and audio files, see the bottom of this post.   Mayo Clinic has initiated the first clinical Hand Transplant Program in the United States and is now enrolling patients. This program offers hand transplantation as a clinically available option for patients with bilateral hand injuries or amputations. This allows patients to [...]

  • Inflammation Causes Some Postsurgical Neuropathies

    Updated: 2010-09-22 15:09:24
    A Mayo Clinic study found that nerve inflammation may cause the pain, numbness and weakness following surgical procedures that is known as postsurgical neuropathy. The development of post-surgical neuropathies is typically attributed to compression or stretching of nerves during surgery. This new research shows that, in some cases, the neuropathy is actually caused by the [...]

  • Mayo Collaborative Study: Early Findings Show Promise Against Bone Marrow Disease

    Updated: 2010-09-16 22:21:43
    Mayo Clinic Cancer Center researchers and collaborators from the M.D. Anderson Cancer Center have found “marked and durable” patient benefits from an experimental drug that inhibits a mutation responsible for myelofibrosis, a serious bone marrow disease that can lead to leukemia. The findings appear in the current New England Journal of Medicine. Researchers conducted a [...]

  • Targeted Therapy Substantially Decreases Progression Rate in Patients With an Aggressive Form of Thyroid Cancer

    Updated: 2010-09-16 15:55:35
    Journalists:  For links to web-video and audio files, see the bottom of this post.   The drug pazopanib may help revolutionize the care of patients with metastatic, rapidly progressive differentiated thyroid cancers, say researchers at Mayo Clinic who are publishing findings of a phase II clinical trial in The Lancet Oncology. The researchers studied 37 patients [...]

  • Asthma Drug May Help MS Patients

    Updated: 2010-09-13 23:37:17
    The bronchodilator albuterol may boost the efficacy of treatment for multiple sclerosis and improve early outcomes, based on results of a small pilot study.

  • Mayo-Led Researchers Discover Genetic Variants Modifying Breast Cancer Risk

    Updated: 2010-09-13 21:22:55
    Journalists:  For links to web-video and audio files, see the bottom of this post. Individuals with disrupting mutations in the BRCA1 gene are known to be at substantially increased risk of breast cancer throughout their lives. Now, discoveries from an international research team led by Mayo Clinic investigators show that some of those persons may [...]

  • Medical Expert for Media – Endocrinology – Maria Collazo-Clavell, M.D.

    Updated: 2010-09-13 14:05:48
    Maria Collazo-Clavell, M.D., expert in obesity and diabetes mellitus Speaks English and Spanish To schedule an interview, call: Media Relations Consultant Bob Nellis (507-284-5005)

  • Protected: Video for News Outlets

    Updated: 2010-09-10 22:23:03
    There is no excerpt because this is a protected post.

  • Kidney Stones

    Updated: 2010-09-09 02:38:00
    What is a kidney stone? A kidney stone is a hard, crystalline mineral material formed within the kidney or urinary tract. Kidney stones are a common cause of blood in the urine and often severe pain in the abdomen, flank, or groin. Kidney stones are sometimes called renal calculi. One in ...

  • Lung Cancer and EGFR

    Updated: 2010-09-09 02:37:58
    Lung Cancer and EGFR Overview A substantial percentage of lung cancers express cell surface epidermal growth factor receptors (EGFRs). As activation of these cell surface receptors has been shown in experimental systems to result in the growth and progression of the malignancy, there have been considerable pre-clinical and clinical research efforts ...

  • Colorectal Cancer and KRAS

    Updated: 2010-09-09 02:37:57
    Colorectal Cancer and KRAS Overview One actively investigated approach in the management of advanced and metastatic colorectal cancer (CRC) has been the delivery of agents whose primary purpose is to interfere with the biological activity of the epidermal growth factor receptor (EGFR). However, it is well-recognized that only a subset of patients ...

  • Chronic Myeloid Leukemia and BCR-ABL

    Updated: 2010-09-09 02:37:56
    Chronic Myeloid Leukemia and BCR-ABL Overview Chronic myeloid leukemia (CML), also known as chronic myelogenous leukemia, is one of the few cancers that is known to caused by a single, specific genetic mutation in more than 90% of cases. The transformation to CML is caused by a reciprocal translocation of the BCR ...

  • Breast Cancer and HER2

    Updated: 2010-09-09 02:37:55
    Breast Cancer and HER2 Overview Approximately 30% of malignant breast cancers demonstrate overamplification of the human epidermal receptor type 2 (HER2) gene, resulting in  an overexpression of the HER2 receptor, a transmembrane tyrosine kinase receptor within the epidermal growth factor receptor (EGFR) family. Activation of this class of cellular receptors is ...

  • Mayo Clinic Awarded $11 Million-plus for Pharmacogenomics

    Updated: 2010-09-07 18:05:34
    Pharmacogenomics – the study of how medication is affected by individual genomes – is a major field of study. It allows physicians to prescribe drugs accurately and safely. One dose does not fit all. In fact, for some a standard medication may have no impact, while for others it may have adverse reactions. Richard Weinshilboum, [...]

Current Feed Items | Previous Months Items

Aug 2010 | Jul 2010